Form 8-K - Current report:
SEC Accession No. 0001731122-26-000502
Filing Date
2026-03-30
Accepted
2026-03-30 17:35:01
Documents
14
Period of Report
2026-03-24
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K e7507_8-k.htm   iXBRL 8-K 33533
2 EXHIBIT 4.1 e7507_ex4-1.htm EX-4.1 53419
3 EXHIBIT 10.1 e7507_ex10-1.htm EX-10.1 33643
4 EXHIBIT 99.1 e7507_ex99-1.htm EX-99.1 6196
  Complete submission text file 0001731122-26-000502.txt   320837

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE lnai-20260324.xsd EX-101.SCH 2990
6 XBRL LABEL FILE lnai-20260324_lab.xml EX-101.LAB 34239
7 XBRL PRESENTATION FILE lnai-20260324_pre.xml EX-101.PRE 22342
17 EXTRACTED XBRL INSTANCE DOCUMENT e7507_8-k_htm.xml XML 3217
Mailing Address CENTURY CITY MEDICAL PLAZA 2080 CENTURY CITY EAST SUITE 906 LOS ANGELES CA 90067
Business Address CENTURY CITY MEDICAL PLAZA 2080 CENTURY CITY EAST SUITE 906 LOS ANGELES CA 90067 45 39179840
Lunai Bioworks Inc. (Filer) CIK: 0001527728 (see all company filings)

EIN.: 452259340 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-38758 | Film No.: 26813615
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)